1. Home
  2. CYTK vs KVYO Comparison

CYTK vs KVYO Comparison

Compare CYTK & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$60.70

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$18.87

Market Cap

5.4B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
KVYO
Founded
1997
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
5.4B
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
CYTK
KVYO
Price
$60.70
$18.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
24
Target Price
$86.00
$36.92
AVG Volume (30 Days)
1.6M
5.3M
Earning Date
05-25-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.29
EPS
N/A
N/A
Revenue
$13,368,000.00
$1,234,019,000.00
Revenue This Year
$37.53
$24.07
Revenue Next Year
$214.81
$19.73
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.63
52 Week Low
$29.31
$15.53
52 Week High
$70.98
$40.60

Technical Indicators

Market Signals
Indicator
CYTK
KVYO
Relative Strength Index (RSI) 38.75 45.09
Support Level $59.23 $15.53
Resistance Level $65.93 $34.18
Average True Range (ATR) 2.59 1.45
MACD -0.74 0.38
Stochastic Oscillator 9.49 52.78

Price Performance

Historical Comparison
CYTK
KVYO

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

Share on Social Networks: